checkAd
    Startseite > Aktien > Krystal Biotech > Nachrichten
    Krystal Biotech Aktie
    156,88
     
    USD
    +0,77 %
    +1,20 USD
    Letzter Kurs 02:00:00 Nasdaq
    156,67
     
    USD
    100 STK
    Geldkurs 26.04.24
    156,91
     
    USD
    100 STK
    Briefkurs 26.04.24
    ISIN: US5011471027 · WKN: A2JH2F · SYM: KRYS · USA

    Neueste Nachrichten

    Krystal Biotech to Report First Quarter 2024 Financial Results on May 6, 2024
    26.04.24 · globenewswire · Krystal Biotech
    Krystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the Lung
    22.04.24 · globenewswire · Krystal Biotech
    Krystal Biotech to Present at the American Association for Cancer Research 2024 Annual Meeting
    04.04.24 · globenewswire · Krystal Biotech
    Krystal Biotech to Present at TD Cowen 44th Annual Health Care Conference
    28.02.24 · globenewswire · Krystal Biotech
    Krystal Biotech Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
    26.02.24 · globenewswire · Krystal Biotech
    Krystal Biotech to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024
    20.02.24 · globenewswire · Krystal Biotech
    Krystal Biotech Receives FDA Fast Track Designation for Inhaled Oncology Candidate KB707 to Treat Solid Tumors of the Lung
    13.02.24 · globenewswire · Krystal Biotech
    Krystal Biotech Announces Publication in the New England Journal of Medicine on the Application of B-VEC to Treat Ocular Complications in Patient with Dystrophic Epidermolysis Bullosa
    08.02.24 · globenewswire · Krystal Biotech
    Krystal Biotech to Present at Guggenheim 6th Annual Biotechnology Conference
    01.02.24 · globenewswire · Krystal Biotech
    Krystal Biotech Receives Permanent J-code (J3401) for VYJUVEK
    04.01.24 · globenewswire · Krystal Biotech
    Krystal Biotech Receives Orphan Drug Designation from the Japanese MHLW for Beremagene Geperpavec-svdt (B-VEC)
    19.12.23 · globenewswire · Krystal Biotech
    Krystal Biotech Announces EMA Validation of Marketing Authorization Application for VYJUVEK for the Treatment of Dystrophic Epidermolysis Bullosa
    27.11.23 · globenewswire · Krystal Biotech